ALBIREO PHARMA INC's ticker is and the CUSIP is 01345P956. A total of 1 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $242 | -99.9% | 11,200 | -5.1% | 0.00% | – |
| Q3 2022 | $228,000 | -0.9% | 11,800 | +1.7% | 0.00% | – |
| Q2 2022 | $230,000 | +289.8% | 11,600 | +480.0% | 0.00% | – |
| Q1 2022 | $59,000 | +118.5% | 2,000 | +66.7% | 0.00% | – |
| Q4 2021 | $27,000 | +285.7% | 1,200 | +500.0% | 0.00% | – |
| Q3 2021 | $7,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | -97.0% | 200 | +198.5% | 0.00% | – |
| Q1 2021 | $236,000 | +807.7% | 67 | +857.1% | 0.00% | – |
| Q4 2020 | $26,000 | -99.1% | 7 | -99.2% | 0.00% | -100.0% |
| Q3 2020 | $2,866,000 | +2682.5% | 859 | +2102.6% | 0.00% | – |
| Q2 2020 | $103,000 | +10200.0% | 39 | +3800.0% | 0.00% | – |
| Q1 2020 | $1,000 | -97.7% | 1 | -94.1% | 0.00% | – |
| Q4 2019 | $43,000 | -62.9% | 17 | -70.7% | 0.00% | – |
| Q3 2019 | $116,000 | +20.8% | 58 | +93.3% | 0.00% | – |
| Q1 2019 | $96,000 | +95.9% | 30 | +50.0% | 0.00% | – |
| Q4 2018 | $49,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |